- Rising Health Costs Push Some Middle-Aged Adults To Skip the Doc Until Medicare
- Even With Dental Insurance, You Still Could Face a Large Bill
- Don't Forget This: Study Shows Cannabis Exacts a Toll on Your Memory
- Want To Stress Less? Start With These Everyday Habits
- Journalists Shine Light on Out-of-Reach Insurance Prices, AI’s Role in Claims Disputes, and Susie Wiles
- Arizona behavioral health center adds 10 adolescent beds
- The explosion of the Medicare Advantage special needs plan
- The explosion of the Medicare Advantage special needs plan
- We’re Great Thinkers…But Not Rethinkers
- North Star to cut additional jobs
- North Star to cut additional jobs
- Oregon Governor asks PeaceHealth to delay contract switch: 11 things to know
- 6 Optum updates to know from Q1
- Viewpoint: US nursing workforce faces several risks
- The shifting dental hygiene landscape
- 12 dental insurance updates in 30 days
- ‘The 1980s called’: CMS to phase out fax, mail
- ‘The 1980s called’: CMS to phase out fax, mail
- Aligning IT & clinical teams: How to reduce friction and improve communication
- AI tool targets billing gaps at Kentucky system
- AI in pharmacy: Why pilots stall at hospitals
- 37 recent hospital, health system executive moves
- This ASC startup is wiring AI into the fabric of outpatient surgery
- Springer Nature retracts 38 papers over autism dataset
- Intermountain plans new outpatient clinic
- Legacy Health, Regence BCBS face looming contract expiration
- Meet the COOs of the largest DSOs
- Michigan bills target outpatient fees, CON requirements
- Anesthesia group, lawmakers oppose Medicare cuts to non-opioid pain treatment
- Iowa lifts emergency suspension of transplant surgeon’s license
- Vascular center, physician CEO to pay $4M to settle fraud allegations
- In the Affordability Alphabet Soup of the ACA and EHBs, a Link to Higher Premiums Isn’t Clear-Cut
- 5 cardiologists stepping into leadership roles
- New York organizations partner on intellectual, developmental disabilities campus
- Cincinnati hospital acquires outpatient center for $6M
- CMS final rule aims to axe the fax machine, phase out paper mailing
- 24 profitable health systems in 2025
- How 2 CFOs plan for uncertainty
- Heartland Dental expands with Texas affiliation
- MD Anderson opens colorectal cancer center
- SALT Dental Partners adds Washington practice
- 11 dental school updates to know
- 6 health systems seeking revenue cycle executive directors
- Remarks at The SEC Speaks in 2026: From Kitchen Table to Cap Table—Making Capital Formation Work for Small Businesses
- Integrated care model drives 76% depression improvement in 44 days: Study
- Heart Benefits From GLP-1 Drugs Fade After Stopping, Study Finds
- Survey Shows More People Struggling To Afford ACA Insurance
- Up to 155,000 COVID Deaths May Not Have Been Counted, Study Finds
- FDA Drops Plan To Ban Tanning Beds for Minors Nationwide
- Idaho bill proposes consolidating dental regulatory oversight
- Washington hospital charts path to preserve primary care
- 4 DSOs making headlines
- 6 state behavioral health policy updates
- 80% of returning ACA enrollees report higher healthcare costs in 2026
- Fitch downgrades HonorHealth’s credit rating
- NYC Health + Hospitals names dentistry, oral surgery leaders
- Mindray North America Enters Ventilator Market
- Mindray North America Enters Ventilator Market
- LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea
- LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea
- Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
- Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
- EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization
- EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization
- With Novo's semaglutide going off patent, Indian drugmakers set to launch their cheaper generics
- Sanofi backs 2 more documentary films about rare blood disorders
- ACIP member's miscommunication on vaccine panel's future adds to confusion after court ruling
- Rhythm's Imcivree scores 'transformative' FDA approval in brain damage-related obesity
- Some Patients With ADHD and Addiction History Missing Out
- Social Media Poses Risks to Children's Mental Health, Review Concludes
- 'Early Bird' Exercisers Get The Most Health Benefits, Study Finds
- Does Closing Your Eyes Help You Hear Better?
- High Blood Pressure Deaths Quadruple Among Young Women, Study Finds
- Meningitis Vaccine Doesn't Protect Gay, Bisexual Men From Gonorrhea, Clinical Trial Concludes
- Oz Escalates Medicaid Fraud Claims Against States After Focus on Minnesota
- Listen: Trump’s NIH ‘Reset’ Is Driving Away Scientists
- ‘How Low Can You Go?’ The Shifting Guidelines for Blood Pressure Control
- Mississippi to fund clinical trials for psychedelic drug
- Lawmakers push bill to boost mental health workforce, diversity
- Florida State partners with behavioral health provider on research
- Utah governor signs hygienist autonomy bill
- UHS CEO: Talkspace deal builds 1st national ‘end-to-end’ behavioral model
- Psychedelic therapy shows no benefit over antidepressants: Study
- What the Health? From KFF Health News: RFK Jr.’s Vaccine Schedule Changes Blocked — For Now
- Verily banks $300M to accelerate AI road map, transitions to independent company
- KFF: ACA plan enrollees report rising costs for 2026 coverage
- Industry Voices—Stop buying AI tools, start designing AI architecture
- CSL warns of supply shortfall, treatment delays for hemophilia gene therapy Hemgenix
- 10K Corewell Health nurses vote to authorize labor strike
- Providence mulling sale of its health plan amid financial pressures
- Fierce Pharma Asia—World's 1st brain chip nod; AZ's cell therapy bet; Astellas-CytomX breakup
- Gut Microbiome May Take Years to Recover From Antibiotic Use
- Prepared Remarks Before SEC Speaks
- The Art and Science of Materiality
- Capital, Choice, and the Pursuit of Happiness: Remarks at The SEC Speaks in 2026
- Novo's Wegovy HD passes muster under FDA national priority voucher program
- Hospital operations begin 2026 with depressed margins amid low volumes, high labor spend
- The Math Behind Eczema Flare-Ups May Finally Add Up
- Male preconception startup Upstream announces donor-matching platform
- Women's health sector could grow to $600B industry by 2030: PwC report
- Democratic senators detail plans to take on 'Big Insurance'
- Both Types Of Diabetes Increase Dementia Risk
- Aldi Recalls Spinach Bites Over Possible Contamination
- Collegium ponies up $650M to gain ADHD drug Azstarys from Corium
- Maryland bill calls for more transparency in pharma's disease awareness campaigns
- After Alfasigma's GSK licensing deal, Lynavoy picks up FDA nod in rare liver disease
- What To Know About Fatty Liver Disease and Why It’s So Common
- Drug Smoking Linked To Surge In Severe Burn Cases
- Thymus Gland Health May Be Key to Long Life and Fighting Cancer
- Premature Menopause Increases Heart Disease Risk
- U.S. Teen Obesity Hits Record Highs While Efforts to Slim Down Drop
- Pesticide Exposure Before Pregnancy Might Risk Newborn Health
- UPDATED: AstraZeneca to build cell therapy manufacturing hub, R&D center in Shanghai
- Many ACA Customers Are Paying Higher Premiums. Most Blame Trump and Republicans, Poll Finds.
- Lawmakers Seek To Protect Crisis Pregnancy Centers as Abortion Clinic Numbers Shrink
- CDMO Axplora to pump $60M into Italian complex API plant
- Pfizer eyes earlier Talzenna use after phase 3 prostate cancer win
- Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia
- Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia
- JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)
- JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)
- Turquoise Health raises $40M to power healthcare contracts, payments
- To tackle healthcare costs, representatives weigh curbs on provider consolidation
- A look at Highmark's specialty pharmacy partnership with Free Market Health
- AD/PD 2026: New data highlight potential cost-effectiveness of confirmatory AD blood testing in U.S. diagnostic pathways
- With downgrade, HSBC casts doubt about Lilly's 'stairway to heaven' trajectory
- TrumpRx's 'world's lowest' drug price claims fall short in global comparison: NYT
- Study Finds Little Proof Cannabis Helps Most Mental Health Conditions
- Meningitis Outbreak Tied to Students Leaves 2 Dead and 11 Sick in England
- J&J, Protagonist's 'game-changer' once-daily psoriasis pill Icotyde nabs FDA approval
- Belly Fat Linked To Heart Failure Risk
- Women More Likely To Survive Cancer Than Men — At A Cost
- BMS brings 'Emily in Paris' star and cancer survivor Ashley Park aboard campaign honoring oncologists
- Sandoz expands biosim collab with Samsung Bioepis, sets sights on Takeda's Entyvio
- Ultra-Processed Foods Linked To Heart Attack, Stroke, Cardiac Arrest
- E. Coli Outbreak Tied To Raw Cheddar Cheese Sickens 7 People
- The Sunshine Vitamin and COVID: New Study Finds Mixed Results for Recovery
- Too Much Smartphone Use Linked to Disordered Eating in Teens
- Shingles Vaccine Protects Heart Failure Patients From Heart Attack, Stroke
- White House Chief of Staff Susie Wiles Diagnosed With Early Breast Cancer
- Gates-backed TerraPower Isotopes blueprints $450M plant to supply next wave of radiopharmaceuticals
- Regulation Crypto Assets: A Token Safe Harbor
- The Last Chapter in the Book of Howey
- Payers, hospitals pan CMS' plan to bring non-network plans to ACA exchanges
- Optum Real and Suki build out collaboration to tackle payment challenges as R1 teams with AI scribe Heidi
- Indiana homes in on life sciences with $1B growth strategy, plan to create 100K jobs
- Moody's: Insurers' 2026 outlook is negative as cost pressures continue to batter industry
- GSK's management of Flovent allowed it to 'game the system': Hassan
- Allina Health to join Sutter Health in $26B proposed transaction
- Norovirus Sickens Close to 200 People on Caribbean Cruise
Morning Break has a wide range today!
Some omitted for length are available at the original link.
https://www.medpagetoday.com/publichealthpolicy/productalert/119393
Chocolate Recalled Nationwide; Testosterone Diet Guidance; Autistic Barbie Launched
— Health news and commentary gathered by MedPage Today staff
January 13, 2026Note that some links may require registration or subscription.
Spring & Mulberry recalled a lot of its Mint Leaf Date Sweetened Chocolate Bar that was sold online and through retail partners nationwide due to possible contamination with Salmonella.
Some lots and flavors of Sea Moss Gel Superfood also were recalled by Diva Fam for lack of temperature monitoring records.
Healthcare giant UnitedHealth Group used aggressive tactics to boost payments for Medicare Advantage members, a Senate report based on 50,000 pages of records found. (Wall Street Journal via MSN)
Democratic leadership sent Republicans a proposal to renew enhanced Affordable Care Act subsidies and other expiring health programs. (Axios)
This week, the U.S. reported 170 new measles cases, according to the Yale School of Public Health. Here are states with new cases.
The recently revised dietary guidelines included a surprising section: "supporting testosterone health in men." (STAT)
Adolescents who used social media most and those who didn't use it at all had higher odds of low well-being in later adolescence, a longitudinal study in Australia showed. (JAMA Pediatrics)
The Environmental Protection Agency will stop considering lives saved and will calculate only the cost to industry when setting air pollution limits. (New York Times)
The FDA issued draft guidance that aimed to modernize statistical methods by using Bayesian approaches in clinical trials of drugs and biologics.
A district court granted the Federal Trade Commission's request for a preliminary injunction to temporarily prevent Edwards Lifesciences from acquiring JenaValve Technology, which the agency alleged would reduce competition for transcatheter aortic valve replacement devices.
Mattel introduced an autistic Barbie doll, alongside other dolls meant to celebrate diversity. (AP)
Results of an unpublished study on pulse oximeter accuracy and skin tone commissioned by the FDA contradicted past findings that the devices overestimate oxygen levels on patients with darker skin. (STAT)
Here's how the growing popularity of in vitro fertilization led to a record number of single moms in their 40s. (NPR)
Football star Tom Brady was named the chief wellness officer of a GLP-1 startup. (Yahoo Finance)
These treatments are dominating the business of living longer. (Washington Post)
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















